276 research outputs found

    Role of preoperative magnetic resonance imaging and histological assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study

    Get PDF
    Preoperative identification of individuals at low risk of lymph node metastasis is key to the proper management of endometrial cancer. This study evaluated the role of preoperative assessment based on magnetic resonance imaging (MRI) and histological analysis in identifying a group having a low risk of lymph node metastasis. Data of 529 patients with endometrial cancer were obtained from a prospective multicenter database, between January 2012 and December 2014. Clinical staging, based on MRI and histological analysis, was compared with final pathology results after the surgical staging procedure. The preoperative low-risk criteria, based on current guidelines from Korea, France, and Canada, and criteria used for fertility-sparing therapies, were applied to our multicenter cohort and the accuracy of each set of criteria for identifying group at low risk of lymph node metastasis was evaluated. When considering grades or MR stages separately, the overall agreement between preoperative and postoperative findings was poor (Kappa 0.45 for grades; 0.41 for stages). However, when combining these two parameters, the low-risk group, as defined by any of the guidelines, had an acceptable rate of lymph node metastasis (below 3%). The French guidelines identified 249 patients (47.1%) as being in the low-risk group. Criteria used to define fertility-sparing therapy candidates identified 48 patients (9.1%) among the study population, only one of whom had extra-uterine disease. This study shows that the current guidelines, using preoperative assessment based on MRI and histological analysis, can identify low-risk patients, who may be candidates for omitting lymphadenectomy.ope

    Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era

    Get PDF
    PURPOSE: Despite the benefits of minimally invasive surgery for cervical cancer, there are a lack of randomized trials comparing laparoscopic radical hysterectomy and abdominal radical hysterectomy. We compared morbidity, cost of care, and survival between abdominal radical hysterectomy and laparoscopic radical hysterectomy for cervical cancer. Materials and Methods: We used the Korean nationwide database to identify women with cervical cancer who underwent radical hysterectomy from January 1, 2011 to December 31, 2014. Patients who underwent abdominal radical hysterectomy were compared to those who underwent laparoscopic radical hysterectomy. Perioperative morbidity, the use of adjuvant therapy, and survival were evaluated after propensity score balancing. RESULTS: We identified 6,335 patients, including 3,235 who underwent abdominal radical hysterectomy and 3,100 who underwent laparoscopic radical hysterectomy. The use of laparoscopic radical hysterectomy increased from 46.1% in 2011 to 51.8% in 2014. Patients who were younger, had a more recent year of diagnosis, and were treated in the metropolitan area were more likely to undergo a laparoscopic procedure (p < 0.001). Compared to abdominal radical hysterectomy, laparoscopic radical hysterectomy was associated with lower rates of complication, fewertransfusions, a shorter hospital stay, less adjuvant therapy, and reduced total medical costs (p < 0.001). Laparoscopic surgery was associated with a better overall survival than abdominal operation (hazard ratio, 0.74; 95% confidence interval, 0.64 to 0.85). CONCLUSION: In the postdissemination era, laparoscopic radical hysterectomy was associated with more favorable morbidity profiles, a lower cost of care, and comparable survival than abdominal radical hysterectomy.ope

    The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study

    Get PDF
    BACKGROUND: Despite recent advances in diagnosis and treatment, cervical cancer continues to be a significant health problem worldwide. Whereas robot-assisted surgery has advantages over the abdominal approach, and minimally invasive techniques are being used increasingly, these may be associated with a higher recurrence rate and lower overall survival than the abdominal approach. The objective of this study was to compare the surgical and survival outcomes between abdominal radical hysterectomy (ARH) and robotic radical hysterectomy (RRH). METHODS: A retrospective cohort of patients undergoing radical hysterectomy for cervical cancer from 2006 to 2018 was identified. Patients with stage IA to IB cervical cancer were included and grouped: ARH vs. RRH. The RRH group was further divided into two groups based on the year of enrollment: RRH1 (2006-2012) and RRH2 (2013-2018). Tumor characteristics, recurrence rate, progression-free survival (PFS), and overall survival (OS) were compared between the groups. P-values < 0.05 (two-sided) were considered statistically significant. RESULTS: A total of 310 patients were identified: 142 and 168 underwent ARH and RRH, respectively. RRH1 and RRH2 had 77 and 91 patients, respectively. Interestingly, RRH2 was more likely to have a larger tumor size (1.7 ± 1.4 vs. 2.0 ± 1.1 vs. 2.4 ± 1.7 cm, P = 0.014) and higher stage (P < 0.001) than RRH1. However, RRH2 showed significantly favorable PFS in contrast to RRH1. There was no difference between ARH and RRH2 in PFS (P = 0.629), whereas overall, the RRH group showed significantly shorter PFS than the ARH group. In the multivariate analysis, the institutional learning curve represented by the operation year was one of the significant predictors for PFS (hazard ratio [HR] 0.065, P = 0.0162), along with tumor size (HR 5.651, P = 0.0241). CONCLUSIONS: The institutional learning curve, represented by the operation year, is one of the most significant factors associated with outcomes of RRH for early-stage cervical cancer.ope

    Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing

    Get PDF
    BACKGROUND: The extent to which metastatic tumors further evolve by accumulating additional mutations is unclear and has yet to be addressed extensively using next-generation sequencing of high-grade serous ovarian cancer. METHODS: Eleven spatially separated tumor samples from the primary tumor and associated metastatic sites and two normal samples were obtained from a Stage IIIC ovarian cancer patient during cytoreductive surgery prior to chemotherapy. Whole exome sequencing and copy number analysis were performed. Omental exomes were sequenced with a high depth of coverage to thoroughly explore the variants in metastatic lesions. Somatic mutations were further validated by ultra-deep targeted sequencing to sort out false positives and false negatives. Based on the somatic mutations and copy number variation profiles, a phylogenetic tree was generated to explore the evolutionary relationship among tumor samples. RESULTS: Only 6% of the somatic mutations were present in every sample of a given case with TP53 as the only known mutant gene consistently present in all samples. Two non-spatial clusters of primary tumors (cluster P1 and P2), and a cluster of metastatic regions (cluster M) were identified. The patterns of mutations indicate that cluster P1 and P2 diverged in the early phase of tumorigenesis, and that metastatic cluster M originated from the common ancestral clone of cluster P1 with few somatic mutations and copy number variations. CONCLUSIONS: Although a high level of intratumor heterogeneity was evident in high-grade serous ovarian cancer, our results suggest that transcoelomic metastasis arises with little accumulation of somatic mutations and copy number alterations in this patient.ope

    Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer

    Get PDF
    BACKGROUND: Poly (ADP-ribose) polymerase inhibitors targeting BRCA1/2 mutations are available for treating patients with high-grade serous ovarian cancer. These treatments may be more appropriately directed to patients who might respond if the tumor tissue is additionally tested by next-generation sequencing with a multi-gene panel and Sanger sequencing of a blood sample. In this study, we compared the results obtained using the next-generation sequencing multi-gene panel to a known germline BRCA1/2 mutational state determined by conventional Sanger sequencing to evaluate the landscape of somatic mutations in high-grade serous ovarian cancer tumors. METHODS: Cancer tissue from 98 patients with high-grade serous ovarian cancer who underwent Sanger sequencing for germline BRCA1/2 analysis were consecutively analyzed for somatic mutations using a next-generation sequencing 170-gene panel. RESULTS: Twenty-four patients (24.5%) showed overall BRCA1/2 mutations. Seven patients (7.1%) contained only somatic BRCA1/2 mutations with wild-type germline BRCA1/2, indicating acquired mutation of BRCA1/2. Three patients (3.1%) showed reversion of germline BRCA1 mutations. Among the 14 patients (14.3%) with both germline and somatic mutations in BRCA1/2, two patients showed different variations of BRCA1/2 mutations. The next-generation sequencing panel test for somatic mutation detected other pathogenic variations including RAD51D and ARID1A, which are possible targets of poly (ADP-ribose) polymerase inhibitors. Compared to conventional Sanger sequencing alone, next-generation sequencing-based tissue analysis increased the number of candidates for poly (ADP-ribose) polymerase inhibitor treatment from 17.3% (17/98) to 26.5% (26/98). CONCLUSIONS: Somatic mutation analysis by next-generation sequencing, in addition to germline BRCA1/2 mutation analysis, should become the standard of care for managing women with high-grade serous ovarian cancer to widen the indication of poly (ADP-ribose) polymerase inhibitors.ope

    Identifying a low-risk group for parametrial involvement in microscopic Stage IB1 cervical cancer using criteria from ongoing studies and a new MRI criterion

    Get PDF
    BACKGROUND: There are currently three ongoing studies on less radical surgery in cervical cancer: ConCerv, GOG-278, and SHAPE. The aim of this study was to evaluate the performance of the criteria used in ongoing studies retrospectively and suggest a new, simplified criterion in microscopic Stage IB1 cervical cancer. METHODS: A retrospective analysis was performed in 125 Stage IB1 cervical cancer patients who had no clinically visible lesions and were allotted based on microscopic findings after conization. All patients had magnetic resonance imaging (MRI) after conization and underwent type C2 radical hysterectomy. We suggested an MRI criterion for less radical surgery candidates as patients who had no demonstrable lesions on MRI. The rates of parametrial involvement (PMI) were estimated for patients that satisfied the inclusion criteria for ongoing studies and the MRI criterion. RESULTS: The rate of pathologic PMI was 5.6% (7/125) in the study population. ConCerv and GOG-278 identified 11 (8.8%) and 14 (11.2%) patients, respectively, as less radical surgery candidates, and there were no false negative cases. SHAPE and MRI criteria identified 78 (62.4%) and 74 (59.2%) patients, respectively, as less radical surgery candidates; 67 patients were identified as less radical surgery candidates by both sets of criteria. Of these 67 patients, only one had pathologic PMI with tumor emboli. CONCLUSIONS: This study suggests that the criteria used in three ongoing studies and a new, simplified criterion using MRI can identify candidates for less radical surgery with acceptable false negativity in microscopic Stage IB1 disease.ope

    μŒμ•… κ°μƒμ˜ μ •μ„œμ‘°μ ˆ κΈ°λŠ₯

    Get PDF
    ν•™μœ„λ…Όλ¬Έ (박사)-- μ„œμšΈλŒ€ν•™κ΅ λŒ€ν•™μ› : 심리학과, 2015. 2. λ―Όκ²½ν™˜.λ³Έ μ—°κ΅¬μ—μ„œλŠ” μŒμ•… κ°μƒμœΌλ‘œ 기뢄을 μ‘°μ ˆν•˜λŠ” λ°©λž΅μ„ μΈ‘μ •ν•˜λŠ” 도ꡬλ₯Ό λ§ˆλ ¨ν•˜κ³  이λ₯Ό μ΄μš©ν•˜μ—¬ μ²­λ…„κΈ° 성인을 λŒ€μƒμœΌλ‘œ μŒμ•… 감상을 톡해 기뢄을 μ‘°μ ˆν•˜λŠ” 방랡 μ‚¬μš©μ—μ„œ μ–΄λ– ν•œ κ°œμΈμ°¨κ°€ λ‚˜νƒ€λ‚˜λŠ”μ§€ νƒμƒ‰ν•˜μ˜€μœΌλ©° μŒμ•…μ΄ μ •μ„œμ˜ 변화에 λ―ΈμΉ˜λŠ” 영ν–₯을 μ„€λ¬Έ 연ꡬ와 μ‹€ν—˜ 연ꡬλ₯Ό ν†΅ν•˜μ—¬ ν™•μΈν•˜μ˜€λ‹€. 연ꡬ 1μ—μ„œλŠ” Music in Mood Regulation Scale(Saarikallio, 2008)을 μ²­λ…„κΈ°μ˜ ν•œκ΅­μΈμ„ λŒ€μƒμœΌλ‘œ νƒ€λ‹Ήν™”ν•˜μ—¬ μ²™λ„μ˜ ꡬ쑰λ₯Ό μ‚΄νŽ΄λ³΄μ•˜λ‹€. ν•œκ΅­νŒ μŒμ•… μ‚¬μš© κΈ°λΆ„μ‘°μ ˆ 척도(K-MMR)λŠ” 6개의 ν•˜μœ„ μš”μΈμœΌλ‘œ 이루어져 있으며 각 ν•˜μœ„ 방랡의 이름은 회볡, λΆ„μΆœ, κ°•λ ¬ν•œ λŠλ‚Œ, 였락, μ£Όμ˜μ „ν™˜, μœ„λ‘œμ˜€λ‹€. 각 μš”μΈμ˜ 신뒰도λ₯Ό κ²€μ¦ν•˜κ³  μˆ˜λ ΄νƒ€λ‹Ήλ„μ™€ 변별타당도λ₯Ό κ²€μ¦ν•¨μœΌλ‘œμ¨ K-MMR이 μ‹ λ’°λ‘­κ³  νƒ€λ‹Ήν•œ λ„κ΅¬μž„μ„ ν™•μΈν•˜μ˜€λ‹€. 연ꡬ 2μ—μ„œλŠ” K-MMR을 μ΄μš©ν•˜μ—¬ μŒμ•… 감상을 ν†΅ν•œ κΈ°λΆ„μ‘°μ ˆ 방랡의 μ‚¬μš©μ—μ„œ 개인의 κ²½ν—˜μ΄λ‚˜ νŠΉμ§ˆμ— λ”°λΌμ„œ μ–΄λ– ν•œ κ°œμΈμ°¨κ°€ λ‚˜νƒ€λ‚˜λŠ”μ§€ νƒμƒ‰ν•˜μ˜€λ‹€. μŒμ•…μ„ κΈ°λŠ₯적이라고 μƒκ°ν•˜λŠ” μ‚¬λžŒλ“€μΌμˆ˜λ‘ μŒμ•…μ„ μ‚¬μš©ν•˜μ—¬ 기뢄을 μ‘°μ ˆν•˜λŠ” κ²½ν–₯을 λ³΄μ˜€κ³ , μŒμ•…μ„ μ‚¬μš©ν•œ κΈ°λΆ„μ‘°μ ˆ λ°©λž΅μ€ 정적 κ°μ •μ˜ κ²½ν—˜κ³Ό μœ μ˜ν•œ 상관이 μžˆμ—ˆλ‹€. 남성보닀 여성이 더 μŒμ•…μœΌλ‘œ 기뢄을 μ‘°μ ˆν•˜λŠ” λ°©λž΅μ„ μ‚¬μš©ν•˜μ˜€μœΌλ©° μŒμ•…μ„ κ΅μœ‘λ°›μ€ 집단이 그렇지 μ•Šμ€ 집단보닀 더 μŒμ•…μœΌλ‘œ 기뢄을 μ‘°μ ˆν•˜λŠ” λ°©λž΅μ„ μ‚¬μš©ν•˜μ˜€λ‹€. μŒμ•…μ„ μ‚¬μš©ν•œ κΈ°λΆ„μ‘°μ ˆ λ°©λž΅μ„ μ˜ˆμΈ‘ν•˜λŠ” μ„±κ²©νŠΉμ§ˆμ€ ν•˜μœ„ λ°©λž΅λ³„λ‘œ μ°¨λ³„μ μœΌλ‘œ λ‚˜νƒ€λ‚¬μœΌλ©°, μŒμ•… 감상을 ν†΅ν•œ κΈ°λΆ„μ‘°μ ˆ 방랡과 κ°€μž₯ κΉŠμ€ 연관이 μžˆλŠ” μ„±κ²©νŠΉμ§ˆμ€ μš°ν˜Έμ„±κ³Ό κ²½ν—˜μ— λŒ€ν•œ κ°œλ°©μ„±μΈ κ²ƒμœΌλ‘œ λ‚˜νƒ€λ‚¬λ‹€. 연ꡬ 3μ—μ„œλŠ” κ²½ν—˜ν•˜λŠ” μ •μ„œμ™€ κ°μƒν•˜λŠ” μŒμ•…μ˜ μ’…λ₯˜μ— 따라 μ •μ„œμ˜ κ°œμ„ μ— 차이가 λ‚˜νƒ€λ‚˜λŠ”μ§€ μ•Œμ•„λ³΄κΈ° μœ„ν•΄ μ‹€ν—˜ 연ꡬλ₯Ό μ‹€μ‹œν•˜μ˜€μœΌλ©°, μ •μ„œ μΈ‘μ •μ˜ 신뒰도λ₯Ό 높이기 μœ„ν•˜μ—¬ μžκΈ°λ³΄κ³ μ™€ μžμœ¨μ‹ κ²½κ³„μ˜ ν™œλ™μ„ λ°˜μ˜ν•˜λŠ” 심전도λ₯Ό λ™μ‹œμ— μΈ‘μ •ν•˜μ˜€λ‹€. 뢄노와 μŠ¬ν””μ˜ 두 가지 μ •μ„œλ₯Ό μœ λ°œν•˜κ³  μœ μΎŒν•œ μŒμ•…κ³Ό ν‰μ˜¨ν•œ μŒμ•…μ„ λ“€λ €μ£Όμ—ˆλŠ”λ°, 자기보고 μƒμ—μ„œλŠ” 유발된 μ •μ„œμ— 관계없이 μœ μΎŒν•œ μŒμ•…μ΄ μ •μ„œ κ°œμ„ μ— νš¨κ³Όμ μ΄μ—ˆμ§€λ§Œ 심박변이도 뢄석결과 λΆ„λ…Έλ₯Ό κ²½ν—˜ν•  λ•ŒλŠ” μœ μΎŒν•œ μŒμ•…μ΄, μŠ¬ν””μ„ κ²½ν—˜ν•  λ•ŒλŠ” ν‰μ˜¨ν•œ μŒμ•…μ΄ 효과적으둜 λ‚˜νƒ€λ‚˜ μœ λ°œμ •μ„œμ™€ μŒμ•…μ’…λ₯˜μ˜ μƒν˜Έμž‘μš©νš¨κ³Όκ°€ λ°œκ²¬λ˜μ—ˆλ‹€. μŒμ•…μ΄ μ •μ„œλ³€ν™”μ— λ―ΈμΉ˜λŠ” νš¨κ³Όμ— μŒμ•…μ— λŒ€ν•œ μΉœμˆ™μ„±, 기질적 μ •μ„œ κ²½ν–₯μ„±κ³Ό 같은 변인은 영ν–₯을 주지 λͺ»ν•˜λŠ” κ²ƒμœΌλ‘œ λ‚˜νƒ€λ‚¬λ‹€.λͺ© μ°¨ μ„œ λ‘  1 심리학적 κ΄€μ μ—μ„œμ˜ μŒμ•…κ³Ό μ •μ„œ 연ꡬ 3 μ •μ„œμ‘°μ ˆ μˆ˜λ‹¨μœΌλ‘œμ„œμ˜ μŒμ•… 8 μ—°κ΅¬μ˜ ν•„μš”μ„± 및 λͺ©μ  20 연ꡬ1. ν•œκ΅­νŒ μŒμ•… μ‚¬μš© κΈ°λΆ„μ‘°μ ˆ μ²™λ„μ˜ 타당화 23 방법 26 κ²°κ³Ό 및 λ…Όμ˜ 30 연ꡬ2. μŒμ•…μ„ ν†΅ν•œ κΈ°λΆ„μ‘°μ ˆ 방랡 μ‚¬μš©μ—μ„œμ˜ 개인차 탐색 39 방법 40 κ²°κ³Ό 및 λ…Όμ˜ 43 연ꡬ3. μŒμ•… 감상이 μ •μ„œλ³€ν™”μ— λ―ΈμΉ˜λŠ” νš¨κ³Όμ„± 확인 55 방법 58 κ²°κ³Ό 및 λ…Όμ˜ 66 μ’…ν•© λ…Όμ˜ 75 μ°Έκ³ λ¬Έν—Œ 85 뢀둝 105 Abstract 122Docto

    μ„±ν–₯점수맀칭(PSM) 및 이쀑차이뢄석(DID) 방법을 μ€‘μ‹¬μœΌλ‘œ

    Get PDF
    ν•™μœ„λ…Όλ¬Έ(석사) -- μ„œμšΈλŒ€ν•™κ΅λŒ€ν•™μ› : ν–‰μ •λŒ€ν•™μ› 곡기업정책학과, 2022. 8. 이석원.This study focused on the fact that many studies have been conducted on the effectiveness of sales and leaseback, but few studies have quantitatively analyzed the financial effects of sales and leaseback support for SMEs. Accordingly, the effect of supporting policy funds was analyzed by comparing the performance of companies supported by the sales and leaseback system operated by the Korea Asset Management Corporation(KAMCO). As previously known, in the case of policy finance support programs, there is a possibility that selection bias will occur in the process of reviewing and deciding whether or not to support it. Therefore, this study tried to minimize the problem of selection bias through the DID(difference-in-difference) after extracting the control group by performing PSM(propensity score matching). According to the analysis results, among the four areas of stability, profitability, activity, and growth, it shows the meaningful effect in stability indicators. Among the stability index, the currant ratio and the loan to sales ratio improved. In the case of profitability index, currant income, operating profit, and the net income to sales ratio increased. Among the activity index, the sales to total assets ratio was improved and in relation to growth index, the current asset growth rate improved. The results of this study suggest useful implications for analyzing the effectiveness of sales and leaseback support for SMEs, and it is also expected that the results will contribute to the activation of research for the effectiveness of sales and leaseback in public sector.λ³Έ μ—°κ΅¬μ˜ λͺ©μ μ€ μ„ΈμΌμ•€λ¦¬μŠ€λ°±μ˜ νš¨κ³Όμ„±κ³Ό κ΄€λ ¨ν•˜μ—¬ κ·Έλ™μ•ˆ μˆ˜λ§Žμ€ 연ꡬ듀이 이루어져 μ™”μœΌλ‚˜ μ€‘μ†ŒκΈ°μ—…μ„ λŒ€μƒμœΌλ‘œ μ„ΈμΌμ•€λ¦¬μŠ€λ°± 지원에 λ”°λ₯Έ 재무효과λ₯Ό κ³„λŸ‰μ μœΌλ‘œ λΆ„μ„ν•œ μ—°κ΅¬λŠ” 거의 μ—†λ‹€λŠ” 점에 μ°©μ•ˆν•˜μ—¬ ν•œκ΅­μžμ‚°κ΄€λ¦¬κ³΅μ‚¬(μΊ μ½”)μ—μ„œ μš΄μ˜ν•˜κ³  μžˆλŠ” μ„ΈμΌμ•€λ¦¬μŠ€λ°± μ œλ„λ₯Ό 지원받은 κΈ°μ—…κ³Ό λΉ„μ§€μ›κΈ°μ—…μ˜ μ„±κ³Όλ₯Ό λΉ„κ΅ν•˜μ—¬ μ •μ±…νš¨κ³Όλ₯Ό ν™•μΈν•΄λ³΄κ³ μž ν•˜μ˜€λ‹€. 기쑴에 μ•Œλ €μ§„ 바와 같이 μ •μ±…κΈˆμœ΅ 지원 ν”„λ‘œκ·Έλž¨μ˜ κ²½μš°μ—λŠ” 지원여뢀λ₯Ό κ²€ν† ν•˜μ—¬ κ²°μ •ν•˜λŠ” κ³Όμ •μ—μ„œ μžκΈ°μ„ νƒμ— μ˜ν•œ 편의 μš”μ†Œκ°€ λ°œμƒν•˜κ²Œ 될 κ°€λŠ₯성이 맀우 크닀. λ”°λΌμ„œ λ³Έ μ—°κ΅¬μ—μ„œλŠ” μ΄λŸ¬ν•œ μ„ νƒνŽΈμ˜μ˜ 문제λ₯Ό μ΅œμ†Œν™”ν•˜κΈ° μœ„ν•΄ μ„±ν–₯점수맀칭(Propensity Score Matching)을 μ‹€μ‹œν•˜μ—¬ λŒ€μ‘°κ΅°μ„ μΆ”μΆœν•˜μ˜€κ³  이쀑차이뢄석(Difference-in-Difference)κ³Ό κ²°ν•©ν•œ λͺ¨ν˜•μ„ ν™œμš©ν•˜μ—¬ κ΄€μ°°ν•  수 μžˆλŠ” νŠΉμ„±κ³Ό 관찰이 λΆˆκ°€λŠ₯ν•œ μ—¬λŸ¬ νŠΉμ„±λ“€μ„ ν†΅μ œν•˜κ³ μž λ…Έλ ₯ν•˜μ˜€λ‹€. λ³Έ 연ꡬλ₯Ό ν†΅ν•œ 싀증뢄석 결과에 λ”°λ₯΄λ©΄ μ•ˆμ •μ„±, μˆ˜μ΅μ„±, ν™œλ™μ„±, μ„±μž₯μ„± 4개 λΆ„μ•Ό μ€‘μ—μ„œ μ•ˆμ •μ„± μ§€ν‘œκ°€ κ°€μž₯ λΆ„λͺ…ν•œ 효과λ₯Ό 보이고 μžˆλŠ” κ²ƒμœΌλ‘œ λ‚˜νƒ€λ‚¬λ‹€. μ•ˆμ •μ„± μ§€ν‘œ 쀑 μœ λ™λΉ„μœ¨, μ°¨μž…κΈˆλ§€μΆœμ•‘λΉ„μœ¨μ΄ κ°œμ„ λ˜μ—ˆμœΌλ©°, μˆ˜μ΅μ„± μ§€ν‘œμ˜ 경우 λ‹ΉκΈ°μˆœμ΄μ΅, μ˜μ—…μ΄μ΅, λ§€μΆœμ•‘μˆœμ΄μ΅μœ¨μ΄ κ°œμ„ λ˜μ—ˆμŒμ„ 확인할 수 μžˆμ—ˆλ‹€. ν™œλ™μ„± μ§€ν‘œμ˜ 경우 μ΄μžμ‚°νšŒμ „μœ¨, μ„±μž₯μ„± μ§€ν‘œμ˜ 경우 μœ λ™μžμ‚°μ¦κ°€μœ¨μ΄ 긍정적 효과λ₯Ό 보이고 있음이 ν™•μΈλ˜μ—ˆλ‹€. μ΄μƒμ˜ κ²°κ³Όλ₯Ό μ’…ν•©μ μœΌλ‘œ νŒλ‹¨ν•΄λ³΄λ©΄ μ„ΈμΌμ•€λ¦¬μŠ€λ°±μ„ 지원받은 기업은 곡μž₯, 건물 λ“±μ˜ μžμ‚°μ„ μš°μ„ λ§€μˆ˜κΆŒ 쑰건으둜 λ§€κ°ν•΄μ„œ μ°¨μž…κΈˆ 회수 λ“± μœ λ™μ„± 뢀쑱을 일차적으둜 ν•΄μ†Œν•˜κ³  이에 λ”°λ₯Έ μ°¨μž…κΈˆ κ°μ†Œλ‘œ μœ λ™λΉ„μœ¨, μœ λ™μžμ‚°μ¦κ°€μœ¨, μ°¨μž…κΈˆλ§€μΆœμ•‘λΉ„μš© λ“± μ•ˆμ •μ„±κ³Ό μ§γ†κ°„μ ‘μ μœΌλ‘œ κ΄€λ ¨λœ μ§€ν‘œκ°€ κ°œμ„ λ˜λŠ” κ²ƒμœΌλ‘œ 보인닀. μœ λ™μ„± 문제λ₯Ό ν•΄κ²°ν•œ 기업은 μš΄μ „μžκΈˆμ„ ν™œμš©ν•˜μ—¬ κΈ°μ—…μ˜ 지속적인 μˆ˜μ΅μ°½μΆœμ„ μœ„ν•œ ν™œλ™μ„ μž¬κ°œν•˜μ—¬ λ‹ΉκΈ°μˆœμ΄μ΅, μ˜μ—…μ΄μ΅μ΄ 일뢀 증가함에 따라 λ§€μΆœμ•‘μˆœμ΄μ΅μœ¨, μ΄μžμ‚°νšŒμ „μœ¨ λ“±μ˜ μˆ˜μ΅μ„±, ν™œλ™μ„± μ§€ν‘œκ°€ κ°œμ„ λ˜μ—ˆλ‹€κ³  μœ μΆ”ν•΄λ³Ό 수 μžˆλ‹€. λ³Έ μ—°κ΅¬μ˜ λΆ„μ„κ²°κ³ΌλŠ” μ€‘μ†ŒκΈ°μ—… μ„ΈμΌμ•€λ¦¬μŠ€λ°± μ§€μ›μ˜ νš¨κ³Όμ„± 뢄석에 μœ μš©ν•œ μ‹œμ‚¬μ μ„ μ œμ‹œν•˜λ©°, 연ꡬ결과가 ν–₯ν›„ μ„ΈμΌμ•€λ¦¬μŠ€λ°± μ‹€μ‹œμ— λ”°λ₯Έ νš¨κ³Όμ„±μ„ νŒŒμ•…ν•˜λŠ” μ—°κ΅¬λΆ„μ•Όμ˜ ν™œμ„±ν™”μ— κΈ°μ—¬ν•˜κΈΈ κΈ°λŒ€ν•œλ‹€.제1μž₯ μ„œλ‘  1 제1절 μ—°κ΅¬μ˜ λ°°κ²½ 및 λͺ©μ  1 제2절 μ—°κ΅¬μ˜ λ²”μœ„ 및 방법 3 제2μž₯ μ€‘μ†ŒκΈ°μ—… ꡬ쑰쑰정과 μ„ΈμΌμ•€λ¦¬μŠ€λ°± 5 제1절 μ€‘μ†ŒκΈ°μ—… ν˜„ν™© 5 제2절 ꡬ쑰쑰정 λŒ€μƒ μ€‘μ†ŒκΈ°μ—… ν˜„ν™© 7 제3절 μ„ΈμΌμ•€λ¦¬μŠ€λ°± ν”„λ‘œκ·Έλž¨ 10 1.μ œλ„μ˜ κ°œμš” 10 2.μΊ μ½”μ˜ μ„ΈμΌμ•€λ¦¬μŠ€λ°± ν”„λ‘œκ·Έλž¨ 운영 11 제3μž₯ 선행연ꡬ κ²€ν†  14 제1절 μ„ΈμΌμ•€λ¦¬μŠ€λ°± κ΄€λ ¨ 선행연ꡬ 14 제2절 μ€‘μ†ŒκΈ°μ—… μ •μ±…μžκΈˆ 지원 κΈ°μ—…μ˜ 재무적 νš¨κ³Όμ„± 연ꡬ 16 제3절 μ„ ν–‰μ—°κ΅¬μ™€μ˜ 차별성 18 제4μž₯ μ—°κ΅¬μ˜ 섀계 20 제1절 연ꡬ방법 및 κ°€μ„€μ„€μ • 20 1.연ꡬ방법 20 2.κ°€μ„€μ˜ μ„€μ • 21 제2절 λ³€μˆ˜μ˜ μ„€μ • 23 1.λ…λ¦½λ³€μˆ˜ 23 2.μ’…μ†λ³€μˆ˜ 24 3.ν†΅μ œλ³€μˆ˜ 25 제3절 자료의 μˆ˜μ§‘ 및 뢄석 방법 26 1.μ„±ν–₯점수맀칭(PSM) 27 2.이쀑차뢄법(DID) 31 제5μž₯ 싀증뢄석 κ²°κ³Ό 34 제1절 κΈ°μˆ ν†΅κ³„ 뢄석 34 제2절 가섀검증 36 1.μ•ˆμ •μ„± μ§€ν‘œ 36 2.μˆ˜μ΅μ„± μ§€ν‘œ 40 3.ν™œλ™μ„± μ§€ν‘œ 44 4.μ„±μž₯μ„± μ§€ν‘œ 47 제3절 가섀검증결과 μš”μ•½ 50 제6μž₯ κ²°λ‘  51 제1절 연ꡬ결과 μš”μ•½ 51 제2절 μ—°κ΅¬μ˜ μ‹œμ‚¬μ  53 제3절 μ—°κ΅¬μ˜ ν•œκ³„ 54석

    Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary

    Get PDF
    PURPOSE: The aim of this study is to evaluate the safety of fertility-sparing surgery as the treatment for patients with primary mucinous epithelial ovarian cancer. MATERIALS AND METHODS: A retrospective study of patients with mucinous ovarian cancer between 1991 and 2010 was performed. The demographics and survival outcomes were compared between patients who underwent fertility-sparing surgery and those who underwent radical surgery. RESULTS: A total of 110 patients underwent primary surgery. At the time of surgery, tumors appeared to be grossly confined to the ovaries in 90 patients, and evidence of metastasis was definite in 20 patients. Of the 90 patients with tumors that appeared to be grossly confined to the ovaries at surgical exploration, 35 (38.9%) underwent fertility-sparing surgery. The Kaplan- Meier curve and the log rank test showed no difference in either recurrence-free survival (p=0.792) or disease-specific survival (p=0.706) between the two groups. Furthermore, there was no significant difference in recurrence-free survival (p=0.126) or disease-specific survival (p=0.377) between the two groups, even when the analysis was limited to women below the age of 40. In a multivariate Cox model, fertility-sparing surgery had no effect on either recurrence-free survival (recurrence hazard ratio [HR], 1.20; 95% confidence interval [CI], 0.25 to 5.71) or disease-specific survival (death HR, 0.88; 95% CI, 0.17 to 4.60). CONCLUSION: Fertility-sparing surgery in primary mucinous cancer grossly confined to the ovaries may be a safe option and one not associated with an increase in recurrence or mortality.ope

    An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer.

    Get PDF
    PURPOSE: Adjuvant chemoradiation following primary surgery is frequently indicated in patients with stage IB cervical cancer. The aim of this study is to evaluate the role of a magnetic resonance imaging (MRI)-based strategy in avoiding trimodality therapy. MATERIALS AND METHODS: We retrospectively reviewed all patients with stage IB cervical cancer treated initially with primary surgery at Seoul National University Hospital. We suggest an alternative triage strategy in which the primary treatment modality is determined based on preoperative MRI findings. Using this strategy, primary surgery is only indicated when there is no evidence of parametrial involvement (PMI) and lymph node metastasis (LNM) in the MRI results; when there is evidence of either or both of these factors, primary chemoradiation is selected. Assuming that this strategy is applied to our cohort, we evaluate how the rate of trimodality therapy is affected. RESULTS: Of the 254 patients in our sample, 77 (30.3%) had at least one category 1 risk factor (PMI, LNM, positive resection margin) upon pathologic examination. If the MRI-based strategy had been applied to our cohort, 168 patients would have undergone primary surgery and 86 would have undergone primary chemoradiation. Only 25 patients (9.8%) would have required trimodality therapy based on an indication of at least one category 1 pathologic risk factor following radical hysterectomy. CONCLUSION: The inclusion of MRI in the decision-making process for primary treatment modality could have reduced the number of patients requiring trimodality therapy based on the indication of a category 1 risk factor from 30.3% to 9.8% in our cohort.ope
    • …
    corecore